Selected Talks

American Society of Nephrology (ASN) Renal Week
Philadelphia, November, 2002
You need a PAID SUBSCRIPTION TO HDCN before you can access this material. A GREY CE Post-Test Link means that the continuing education credit feature is not yet ready for use.

Resistant Hypertension: Case Discussions. Part Two.
Robert D. Toto, M.D.

Resistant Hypertension: Case Discussions. Part One.
Robert D. Toto, M.D.

New Treatment Approaches and Clinical Trials in Lupus Nephritis
Gerald B. Appel, M.D.

Clinical Strategies to Minimize Glucose Toxicities to the Peritoneal Membrane
Achim Jörres, M.D.

Adsorptive Techniques Applied to Treat ESRD
James Winchester, M.D.

Bone Biopsy
Stuart Sprague, D.O.

Changes in Vascular Compliance in Chronic Renal Disease - Basic Principles. Part 1 of 2
Gerard London, M.D.

Changes in Vascular Compliance in Chronic Renal Disease. Clinical Implications. Part 2 of 2
Gerard London, M.D.

Nutritional Management of the Critically Ill Patient
T. Alp Ikizler, M.D.

Cannulation of Vascular Grafts and Fistulas
Deborah Brouwer, R.N., C.N.N.

Induction Therapy
Daniel Brennan, M.D.

Are the New Immunosuppressants Improving Kidney Transplant Outcomes?
Sundaram Hariharan, M.D.

Resistant Infection in Dialysis Patients
Jerome Tokars, M.D., M.P.H.

Avoiding Resistant Infection in Dialysis Patients
Lynda Szczech, M.D.

Renal Replacement Therapy for ARF in Liver Disease: Why, What, When and Where
Thomas Gonwa, M.D.

Epidemiology of Kidney Stone Disease
Gary Curhan, M.D.

Ideal Actions of Anti-Hypertensive Drugs
Luis Ruilope, M.D.

Renal Autoregulation and Hypertension Injury: Do All Agents that Lower Blood Pressure Protect the Kidney?
Karen Griffin, M.D.

The Malnutrition - Inflammation - Atherosclerosis (MIA) Syndrome
Peter Stenvinkel, M.D.

Pathophysiology of the Stone Diseases
John Asplin, M.D.

Hypercalcemia and Hypocalcemia: Associated Disorders and Therapy
Wadi Suki, M.D.

The New PD DOQI Guidelines
John Burkart, M.D.

New Developments in Nephrolithiasis
John Asplin, M.D.

Treatment Trials in Kidney Stone Disease
Frederic Coe, M.D.

Role of the Sympathetic Nervous System in the Control of Hypertension
Vito Campese, M.D.

Microalbuminuria: The Kidney's Message About the Systemic Vasculature
Katherine Tuttle, M.D.
(More to come!)

Please look also at related talks from
2001 ASN Annual Meeting Talks
2000 ASN Annual Meeting Talks
1999 ASN Annual Meeting Talks

  1. Facilitate the exchange of state-of-the-art scientific advances within the renal community.
  2. Expose the renal community to exciting advances in related fields to further expand the breadth of research in nephrology.
  3. Facilitate the exchange of ideas regarding clinical advances in the field of nephrology and present the most recent major studies with impact on the filed to the renal community.
  4. Review current practices and established approaches to clinical care for the practicing clinician.

Gerald Appel, M.D. Professor of Clinical Medicine with Tenure of Title and Director of Clinical Nephrology at Columbia University.

John Asplin, M.D. Assistant Professor of Medicine, University of Chicago School of Medicine, Chicago, IL.

Daniel Brennan, M.D. Associate Professor of Medicine and Director of Transplant Nephrology at Washington University School of Medicine.

Deborah Brouwer, R.N., C.N.N. Education and Development Coordinator, Allegheny General Hospital, Dialysis Unit, Allegheny, PA.

John Burkart, M.D. Professor of Internal Medicine and Nephrology, Wake Forest School of Medicine, Winston-Salem, NC.

Vito Campese, M.D. Professor of Medicine and Chief, Division of Nephrology and Hypertension at the LAC-USC Keck School of Medicine, Los Angeles, CA.

Frederic Coe, M.D. Professor of Internal Medicine and Nephrology, Wake Forest University School of Medicine, Winston-Salem, NC.

Gary Curhan, M.D. Associate Professor of Internal Medicine, Harvard Medical School, Associate Physician, Brigham and Women's Hospital, Massachusetts General Hospital, Boston, MA.

Thomas Gonwa, M.D. Professor of Medicine at Mayo Medical School and Medical Director of Renal and Pancreas Transplant at Mayo Clinic, Jacksonville, FL.

Karen Griffin, M.D. Professor of Internal Medicine and Nephrology, Loyola University Stritch School of Medicine, Maywood, IL.

Sundaram Hariharan, M.D. Professor of Internal Medicine and Nephrology, Medical College of Wisconsin, Milwaukee, WI.

T. Alp Ikizler, M.D. Assistant Professor of Medicine at Vanderbilt University Medical Center, and Medical Director of the Vanderbilt University Outpatient Dialysis Unit, Nashville, Tennessee.

Achim Jörres, M.D. PrivatDozent and Head, Peritoneal Dialysis Research Group, Charité University Hospital, Campus Virchow-Klinikum, Humboldt-University Berlin.

Gerard London, M.D. Chief of Nephrology at Manhes Hospital, Paris, France.

Luis Ruilope, M.D. Associate Professor of Internal Medicine and Nephrology, Complutense University; Head, Hypertension Unit, Hospital 12 de Octubre, Madrid, Spain.

Stuart Sprague, D.O. Associate Professor of Medicine at Northwestern University School of Medicine, Director, Metabolic Bone and Stone Disease Program, Evanston Hospital, Evanston Hospital, Il.

Peter Stenvinkel, M.D. Associate Professor, Karolinska Institute; Senior Lecturer, Huddinge University Hospital; Stockholm, Sweden.

Wadi Suki, M.D. Clinical Professor of Medicine, Baylor College of Medicine, Houston, TX.

Lynda Szczech, M.D. Assistant Professor of Medicine, Duke University School of Medicine, Durham, NC.

Jerome Tokars, M.D., M.P.H. Epidemiologist with the Division of Health Care Quality Promotion at the Centers for Disease Control and Prevention in Atlanta.

Robert D. Toto, M.D. Professor of Medicine with Tenure and Director of Patient-Oriented Research in Nephrology; University of Texas Southwestern Medical Center, Dallas, TX.

Katherine Tuttle, M.D. Associate Clinical Professor of Medicine, University of Washington, Seattle, WA. Director of Research at The Heart Institute of Spokane.

James Winchester, M.D. Chief Medical Officer, RenalTech International, New York.

Each talk, depending on its length, is accredited for up to 1.0 CME credit hours by the American Society of Nephrology. Shorter talks are organized into groups of two and paired with a CME post-test, which must be completed along with an evaluation form for 1.0 hour or more of CME credit. Selected talks are also configured to yield CE Nursing Education credits, provided by the Renal Education Association.


Date of Original Release: See individual talks
CME / CE Credit Eligible Through: See individual talks
CME / CE Credit Hours/Completion Time: See individual talks
Target Audiences: For CME accredited talks: Nephrology Board and Recertification candidates practicing nephrologists and internists
For CE accredited talks: Nephrology Nurses and Technicians.
Method of participation: Listen to the talk, read the PubMed abstracts linked to data slides and talk references, take the post-test, read the abstracts linked to post-test answer feedback material.

STATEMENT OF NEED :
Chronic kidney disease affects 30-40 million Americans, of whom several thousand require renal replacement therapy. These selected lectures are chosen by the HDCN editor and ASN Postgraduate Medical Director to reflect those areas of practice of greatest interest to the clinician, and areas where recent progress has occurred. The web extension of these ASN lectures will allow nephrologists and other physicians who were unable to attend the live sessions to gain similar benefit from these presentations. Similarly, those talks chosen for Nursing CEs will allow nephrology nurses, pharmacists, and technicians to also get the educational benefit of this material.

ACCREDITATION STATEMENTS:
(1) The American Society of Nephrology is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

(2) The Renal Education Association is accredited by the State of California Board of Nursing to provide continuing education for nurses (Provider number: CEP 13092).
DESIGNATION STATEMENTS:
(1) The American Society of Nephrology designates this educational activity for category 1 credit toward the AMA Physician's Recognition Award. Each physician should claim only those hours of credit that he/she actually spent in the activity.

(2) The Renal Education Association designates this educational activity for continuing education credits (CEs) for nurses. Each nurse should claim only those hours of credit that he/she actually spent in the activity.
FACULTY DISCLOSURE STATEMENTS :

American Society of Nephrology, the Renal Education Association, as well as HDCN have conflict of interest policies that requires course faculty to disclose any real or apparent commercial financial affiliations related to the content of their presentations/materials. It is not assumed that these financial interests or affiliations will have an adverse impact on faculty presentations; they are simply noted here to fully inform participants.

Dr. Appel: No financial relationships with commercial entities related to his presentation
Dr. Asplin: No financial relationships with commercial entities related to his presentation
Dr. Burkart: Grant support, consultancy, Baxter.
Dr. Campese: Grants/research support: Merck; honoraria: Merck, Pfizer, Bristol-Myers Squibb.
Dr. Brennan: Grant/research support from Novartis, Roche, SangStat, Fujisawa, NIH; and honoraria from: Novartis, Roche, SangStat, Fujisawa.
Ms. Brouwer: No financial relationships with entities related to her presentation.
Dr. Coe: Interest in Litholink
Dr. Curhan: No financial relationships with commercial entities related to his presentation
Dr. Gonwa: No financial relationships with commercial entities related to his presentation
Dr. Griffin: No financial relationships with commercial entities related to his presentation
Dr. Hariharan: Grants, research support: Hoffman La Roche; Honoraria: Fujisawa; Board Position: Novartis.
Dr. Ikizler: No listed conflicts of interest.
Dr. Jörres: No listed conflicts of interest.
Dr. London: No listed conflicts of interest.
Dr. Ruilope: Grants/research support: Merck, Bristol-Myers Squibb, Novartis, Knoll; scientific advisor: Merck, Bristol-Myers Squibb, Novartis, Bayer.
Dr. Sprague: Grants/research support: Abbott, Amgen, Bone Care International, Baxter; consultant: Abbott, Baxter; honoraria: Abbott, Bone Care International, Genzyme; other: Abbott, Amgen.
Dr. Stenvinkel: Board position: Baxter; scientific advisor: Fresenius.
Dr. Suki: No financial relationships with commercial entities related to his presentation
Dr. Szczech: No financial relationships with commercial entities related to his presentation
Dr. Tokars: No financial relationships with commercial entities related to his presentation
Dr. Toto: No financial relationships with commercial entities related to his presentation. Dr. Tuttle: Grants/research support: AstraZeneca, Novartis; honoraria: Merck, Wyeth, Pfizer.
Dr. Winchester: Grants/research support: Grants/research support from RenalTech International.

DISCLOSURE OF UNLABELED USE:
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by FDA. The American Society of Nephrology, the Renal Education Association, and HDCN do not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

DISCLAIMER:
Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications on dangers in use, review of any applicable manufacturer's product information, and comparison with recommendations of other authorities.

USER INSTRUCTIONS:
To complete this educational activity, the user will need Windows or Macintosh operating software, a connection to the internet with a 28.8 kbps MODEM or better. The computer should have an audio card with speakers. An audio player, either the Windows Media Player from Microsoft or the Real Player from Real Media (www.real.com) is required and either can be downloaded for free per instructions on the individual lecture pages. Acrobat Reader is required to print the CME or CE certificate, and this can be download free from www.adobe.com.

For any questions concerning this activity please send an email to or call HDCN at 630-325-3276.